中国癌症杂志 ›› 2018, Vol. 28 ›› Issue (8): 577-583.doi: 10.19401/j.cnki.1007-3639.2018.08.003

• 论著 • 上一篇    下一篇

结直肠癌及腺瘤患者CD4+、CD8+和CD28+T淋巴细胞的亚群变化及临床意义

张 泉,邱思芳,赵 逵,朱 蓉,汪煜鹏,张 海,牟兰兰   

  1. 遵义医学院附属医院消化内科,贵州遵义 563000
  • 出版日期:2018-08-30 发布日期:2018-09-14
  • 通信作者: 赵 逵 E-mail: kuizhao95868@msn.com
  • 基金资助:
    国家自然科学基金资助项目(81560467);贵州省高层次人才科研条件特助基金资助项目(TZIF2011-32);
    贵州省科学技术基金资助项目(LKZ2013-18);遵义医学院博士科研启动基金(F-572);
    贵州省卫生计生委科学技术基金项目(gzwjkj2017-1-001)。

Subsets and clinical significance of CD4+, CD8+ and CD28+ T lymphocytes in the patients with colorectal carcinoma and adenoma

ZHANG Quan, QIU Sifang, ZHAO Kui, ZHU Rong, WANG Yupeng, ZHANG Hai, MOU Lanlan   

  1. Department of Gastroenterology, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, Guizhou Province, China
  • Published:2018-08-30 Online:2018-09-14
  • Contact: ZHAO Kui E-mail: kuizhao95868@msn.com

摘要: 背景与目的:结直肠癌(colorectal cancer,CRC)严重影响患者生存。探讨肿瘤微环境(tumor microenvironment,TME)T细胞亚群在CRC和腺瘤中的表达及意义。方法:用免疫组织化学法和流式细胞术对51例健康人(对照组)、46例结直肠腺瘤(腺瘤组)、100例CRC(癌症组)和15例CRC术后(癌术后组)患者进行T细胞亚群检测。结果:① 对照组、腺瘤组及癌症组3组中CD4+T细胞的阳性率分别是90.00%、43.75%及32.65%,CD8+T淋巴细胞的阳性率分别是30.00%、56.25%及75.51%,CD28+T淋巴细胞的阳性率分别是42.86%、30.00%及20.00%。② 对照组、腺瘤组及癌症组3组中CD4+、CD4+/CD8+、CD28+、CD8+CD28+和CD8CD28+逐渐降低,CD8+、CD8+CD28逐渐增加(P<0.05);癌术前术后T细胞亚群差异有统计学意义(P<0.05)。结论:① CRC微环境T细胞亚群中CD4+、CD4+/CD8+、CD28+、CD8+CD28+和CD8CD28+呈递减趋势,CD8+、CD8+CD28呈递增趋势,且在癌前病变腺瘤中已逐步出现上述趋势变化。② CRC患者行肿瘤切除术后,其T细胞亚群有所恢复,故在一定程度上,CRC中T细胞亚群的变化可以早期预测结直肠疾病的发展。

关键词: 肿瘤微环境, 结直肠癌, 结直肠腺瘤, T淋巴细胞亚群, 流式细胞术

Abstract: Background and purpose: Colorectal cancer (CRC) is a disease that seriously affects the quality of life. This study aimed to investigate the subsets and significance of tumor cell microenvironment T cell in CRC and adenoma. Methods: Immunohistochemistry and flow cytometry were used to test T lymphocyte subsets in 51 healthy subjects (control group), 46 patients with colorectal adenomas (adenoma group), 100 CRC patients (cancer group), and 15 postoperative patients with CRC (postoperative group). Results: The positive rates of CD4+ T cells in the control group, adenoma group and cancer group were 90.00%, 43.75% and 32.65%, respectively. The positive rates of CD8+ T lymphocytes were 30.00%, 56.25% and 75.51%, respectively. The positive rates of CD28+ T lymphocytes were 42.86%, 30.00% and 20.00%, respectively. The levels of CD4+, CD4+/CD8+, CD28+, CD8+CD28+ and CD8CD28+ in the control group, adenoma group and cancer group gradually decreased, while the CD8+ and CD8+CD28 levels gradually increased (P<0.05). The difference in T cell subsets between preoperative and postoperative patients was statistically significant (P<0.05). Conclusion: CD4+, CD4+/CD8+, CD28+, CD8+CD28+ and CD8CD28+ in the subgroup of colorectal tumor microenvironment showed a declining trend, while CD8+ and CD8+CD28showed an increasing trend. Moreover, these trends gradually appeared in precancerous adenomas. After CRC patients underwent tumor resection, their T cell subsets recovered. Therefore, to some extent, the changes of T cell subsets in CRC can predict the development of colorectal disease early.

Key words: Tumor microenvironment, Colorectal cancer, Colorectal adenoma, T lymphocyte subsets, Flow cytometry